Key Events This Week
1 June: Intraday high surge to Rs.47.29 with 8.52% gain and record volume
1 June: Downgrade to Strong Sell by MarketsMOJO amid financial concerns
3 June: Technical momentum shifts to sideways trend with mixed signals
4 June: Upgrade to Sell rating reflecting technical improvements
5 June: Week closes at Rs.43.78, up 1.09% versus Sensex decline
Morepen Laboratories Ltd Gains 14.57%: 5 Key Factors Driving the Week’s Rally
2026-06-13 13:06:11
Key Events This Week
8 June: Stock opens at Rs.42.81, down 2.22%
9 June: Intraday high surge of 13.62% with exceptional volume
10 June: Continued volume surge and positive price momentum
11 June: Price correction of 4.25%
12 June: Intraday high with 7.26% surge, closing at Rs.50.16

Morepen Laboratories Ltd Surges 7.26% to Day's High of Rs 50.9 — Outperforms Sector by 7.06 Percentage Points
2026-06-12 14:01:24The Sensex rose 1.69% on 12 Jun 2026, yet Morepen Laboratories Ltd outpaced the broader market with a 7.26% gain, reaching an intraday high of Rs 50.9. This 7.06 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a general market uplift.
Read full news article
Morepen Laboratories Ltd Sees Exceptional Volume Surge Amid Positive Price Momentum
2026-06-10 11:00:08Morepen Laboratories Ltd (MOREPENLAB) has emerged as one of the most actively traded stocks in the Pharmaceuticals & Biotechnology sector, registering a remarkable surge in volume and price momentum. The stock’s recent performance, coupled with significant accumulation signals, has attracted heightened investor attention despite its current sell rating.
Read full news article
Morepen Laboratories Ltd Sees Technical Momentum Shift Amid Mixed Market Signals
2026-06-10 08:03:07Morepen Laboratories Ltd has experienced a notable shift in price momentum, reflected in a 13.62% surge in its share price to ₹48.64 on 10 Jun 2026. Despite this sharp daily gain, the stock’s technical indicators present a complex picture, with a transition from a mildly bearish trend to a sideways movement, signalling a potential consolidation phase for this pharmaceuticals and biotechnology small-cap.
Read full news article
Morepen Laboratories Surges on Exceptional Volume Amid Trend Reversal
2026-06-09 14:00:08Morepen Laboratories Ltd (MOREPENLAB) witnessed a remarkable surge in trading volume on 9 June 2026, emerging as one of the most actively traded stocks in the Pharmaceuticals & Biotechnology sector. The stock reversed a five-day losing streak, rallying 14.13% intraday and outperforming its sector by 12.55%, signalling renewed investor interest despite a recent downgrade in its Mojo Grade.
Read full news article
Morepen Laboratories Ltd Surges 10.09% to Day's High of Rs 47.04 — Outperforms Sector by 8.74 Percentage Points
2026-06-09 12:01:41The Sensex edged up 0.18% on 09 Jun 2026, but Morepen Laboratories Ltd outpaced the broader market with a sharp 10.09% gain, touching an intraday high of Rs 47.04. This 8.74 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift.
Read full news article
Morepen Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-06-09 08:01:01Morepen Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock’s price action and technical indicators reveal a nuanced picture that investors should carefully analyse.
Read full news articleReply To Clarification On Price Movement
10-Jun-2026 | Source : BSEPlease find enclosed the reply
Clarification sought from Morepen Laboratories Ltd
10-Jun-2026 | Source : BSEThe Exchange has sought clarification from Morepen Laboratories Ltd on June 10 2026 with reference to Movement in Volume.
The reply is awaited.
Announcement under Regulation 30 (LODR)-Investor Presentation
27-May-2026 | Source : BSEPlease find enclosed Investor Presentation on Q4 & FY26 Results
Corporate Actions
No Upcoming Board Meetings
Morepen Laboratories Ltd has declared 10% dividend, ex-date: 29 Aug 25
No Splits history available
No Bonus history available
No Rights history available







